Dr Reddy’s Laboratories has received an establishment inspection reportΒ (EIR) for Bachupally unit, Hyderabad, after the closure of its audit from the US Food and Drug...
Dr Reddy’s Laboratories has received Establishment Inspection Report (EIR), for itsΒ Miyapur facility, Hyderabad, Telangana. The Custom Pharmaceutical Services facility, of Dr Reddyβs Laboratories at the...
Dr Reddy’s Laboratories has received first cycle new drug application (NDA) approval, from the US health regulator, for its Impoyz cream used for treating psoriasis....
TheΒ German regulatory authority has given approval to Dr Reddy’s, Visakhapatnam based plant to restart production for the European market (EU). In a regulatory filing the...
Dr.Reddy’s Laboratories has receivedΒ an establishment inspection report (EIR), for its formulation manufacturing facility at Duvvada in Visakhapatnam, from the US health regulator. The company has...
Dr Reddy’s Laboratories has obtained establishment inspection report(EIR) forΒ a unit of its Β Srikakulam plant in Andhra Pradesh, from the US health regulator. In a filing...
Dr Reddy’s Laboratories (DRL) has launched Bivalirudin injection which is indicated for use as an anti-coagulant in patients, after getting approval from the US health...
On Thursday, Dr Reddy’s Laboratories has announced the launch of tablets of cholesterol lowering generic combination drugs Ezetimibe and Simvastatin in the US. The company...
Dr Reddy’s has launched generic Progesterone capsules that are used in the treatment of menstrual irregularities and protection of the lining of uterus in the...